Mannatech (NASDAQ:MTEX) Coverage Initiated at initiated coverage on shares of Mannatech (NASDAQ:MTEXGet Rating) in a research note issued to investors on Sunday. The firm set a “strong-buy” rating on the stock.

Separately, TheStreet cut shares of Mannatech from a “b” rating to a “c+” rating in a research note on Tuesday, June 7th.

Mannatech Price Performance

Shares of MTEX stock opened at $18.23 on Friday. The stock has a market cap of $34.82 million, a P/E ratio of 5.90 and a beta of 1.14. The company has a fifty day moving average price of $20.34 and a two-hundred day moving average price of $25.67. Mannatech has a one year low of $15.49 and a one year high of $43.10.

Institutional Trading of Mannatech

A hedge fund recently raised its stake in Mannatech stock. LSV Asset Management grew its stake in Mannatech, Incorporated (NASDAQ:MTEXGet Rating) by 1,090.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,142 shares of the company’s stock after purchasing an additional 6,542 shares during the quarter. LSV Asset Management owned approximately 0.37% of Mannatech worth $261,000 as of its most recent SEC filing. 23.74% of the stock is owned by institutional investors.

About Mannatech

(Get Rating)

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Stories

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with's FREE daily email newsletter.